Clinical trial
Clinical Trial of Tolcapone for Cognition in Schizophrenia
NCT00044083 · National Institute of Mental Health (NIMH), NIH · Terminated
Key facts
| NCT number | NCT00044083 |
|---|---|
| Title | Clinical Trial of Tolcapone for Cognition in Schizophrenia |
| Official title | Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug, Other |
| Interventions | Placebo, Tolcapone |
| Enrollment | 210 |
| Start date | Aug 1, 2002 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Aug 19, 2002 |
| Last update posted | Sep 27, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: